Literature DB >> 26178171

Synthesis of New Phosphahelicene Scaffolds and Development of Gold(I)-Catalyzed Enantioselective Allenene Cyclizations.

Paul Aillard1, Pascal Retailleau1, Arnaud Voituriez2, Angela Marinetti3.   

Abstract

This paper reports on the development of an efficient synthesis of enantiopure phospha[6]helicenes through a [2+2+2] alkyne cyclotrimerization reaction. The corresponding gold complexes proved to be highly efficient both in terms of catalytic activity and enantioselectivity in [2+2] and [4+2] cycloaddition reactions. Furthermore, in the presence of an external nucleophile, such as water or alcohols, the tandem cyclization/addition reactions take place in high yields and excellent diastereo- and enantioselectivities.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  allenenes; cyclotrimerization; enantioselectivity; gold catalysis; phosphahelicenes

Year:  2015        PMID: 26178171     DOI: 10.1002/chem.201501697

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  3 in total

1.  Phosphahelicenes: From Chiroptical and Photophysical Properties to OLED Applications.

Authors:  Keihann Yavari; Wylliam Delaunay; Nicolas De Rycke; Thibault Reynaldo; Paul Aillard; Monika Srebro-Hooper; Victoria Y Chang; Gilles Muller; Denis Tondelier; Bernard Geffroy; Arnaud Voituriez; Angela Marinetti; Muriel Hissler; Jeanne Crassous
Journal:  Chemistry       Date:  2019-03-12       Impact factor: 5.236

2.  A rhodium catalyzed cycloisomerization and tandem Diels-Alder reaction for facile access to diverse bicyclic and tricyclic heterocycles.

Authors:  Yirong Zhou; Ali Nikbakht; Felix Bauer; Bernhard Breit
Journal:  Chem Sci       Date:  2019-04-03       Impact factor: 9.825

Review 3.  New-Generation Ligand Design for the Gold-Catalyzed Asymmetric Activation of Alkynes.

Authors:  Giuseppe Zuccarello; Imma Escofet; Ulysse Caniparoli; Antonio M Echavarren
Journal:  Chempluschem       Date:  2021-09       Impact factor: 2.863

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.